ATE125257T1 - Azaindole, deren herstellungsverfahren und sie enthaltende arzneimittel. - Google Patents

Azaindole, deren herstellungsverfahren und sie enthaltende arzneimittel.

Info

Publication number: ATE125257T1
Authority: AT; Austria
Prior art keywords: cycloalkyl; alkyl; optionally substituted; phenyl; benzyl
Prior art date: 1992-02-14

Application number

AT93400366T

Other languages

English (en)

Inventor

Didier Festal

Denis Descours

Jacques Decerprit

Original Assignee

Lipha

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-02-14

Filing date

1993-02-12

Publication date

1995-08-15

1993-02-12 Application filed by Lipha filed Critical Lipha

1995-08-15 Application granted granted Critical

1995-08-15 Publication of ATE125257T1 publication Critical patent/ATE125257T1/de

Links

BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
229940126601 medicinal product Drugs 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 5
125000000753 cycloalkyl group Chemical group 0.000 abstract 5
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 3
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 2
-1 R5 and R6 denote H Chemical group 0.000 abstract 2
YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 abstract 2
125000003342 alkenyl group Chemical group 0.000 abstract 2
125000004414 alkyl thio group Chemical group 0.000 abstract 2
125000000392 cycloalkenyl group Chemical group 0.000 abstract 2
229910052736 halogen Inorganic materials 0.000 abstract 2
150000002367 halogens Chemical class 0.000 abstract 2
XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 abstract 1
125000004183 alkoxy alkyl group Chemical group 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
125000006350 alkyl thio alkyl group Chemical group 0.000 abstract 1
125000002947 alkylene group Chemical group 0.000 abstract 1
230000000879 anti-atherosclerotic effect Effects 0.000 abstract 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000004985 dialkyl amino alkyl group Chemical group 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
125000000623 heterocyclic group Chemical group 0.000 abstract 1
125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 abstract 1
230000000055 hyoplipidemic effect Effects 0.000 abstract 1
125000001624 naphthyl group Chemical group 0.000 abstract 1
229910052757 nitrogen Inorganic materials 0.000 abstract 1
IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 1
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract 1
229930192474 thiophene Natural products 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Hematology (AREA)
Obesity (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Indole Compounds (AREA)

AT93400366T 1992-02-14 1993-02-12 Azaindole, deren herstellungsverfahren und sie enthaltende arzneimittel. ATE125257T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9201701A FR2687402B1 (fr)	1992-02-14	1992-02-14	Nouveaux azaindoles, procedes de preparation et medicaments les contenant.

Publications (1)

Publication Number	Publication Date
ATE125257T1 true ATE125257T1 (de)	1995-08-15

Family

ID=9426663

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT93400366T ATE125257T1 (de)	1992-02-14	1993-02-12	Azaindole, deren herstellungsverfahren und sie enthaltende arzneimittel.

Country Status (27)

Country	Link
US (1)	US5338849A (de)
EP (1)	EP0557171B1 (de)
JP (1)	JPH061788A (de)
KR (1)	KR930017905A (de)
AT (1)	ATE125257T1 (de)
AU (1)	AU658475B2 (de)
CA (1)	CA2089470A1 (de)
CZ (1)	CZ16893A3 (de)
DE (1)	DE69300268T2 (de)
DK (1)	DK0557171T3 (de)
ES (1)	ES2076827T3 (de)
FR (1)	FR2687402B1 (de)
GR (1)	GR3017614T3 (de)
HR (1)	HRP930180A2 (de)
HU (1)	HUT64067A (de)
IL (1)	IL104573A0 (de)
LT (1)	LT3065B (de)
LV (1)	LV10453B (de)
MA (1)	MA22797A1 (de)
MX (1)	MX9300745A (de)
NO (1)	NO930505L (de)
NZ (1)	NZ245869A (de)
OA (1)	OA09775A (de)
SI (1)	SI9300076A (de)
SK (1)	SK9093A3 (de)
TN (1)	TNSN93016A1 (de)
ZA (1)	ZA93844B (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9226855D0 (en) *	1992-12-23	1993-02-17	Erba Carlo Spa	Vinylene-azaindole derivatives and process for their preparation
US5547966A (en) *	1993-10-07	1996-08-20	Bristol-Myers Squibb Company	Aryl urea and related compounds
DE69728688T2 (de)	1996-11-19	2004-08-19	Amgen Inc., Thousand Oaks	Aryl und heteroaryl substituierte kondensierte pyrrole als entzündunghemmende mittel
ES2221213T3 (es)	1997-10-20	2004-12-16	F. Hoffmann-La Roche Ag	Inhibidores de kinasa biciclicos.
CN1131855C (zh) *	1997-12-16	2003-12-24	沃尼尔·朗伯公司	1－取代－1－氨基甲基－环烷衍生物(=加巴喷丁类似物)、其制备及其在治疗神经病方面的用途
US6187777B1 (en)	1998-02-06	2001-02-13	Amgen Inc.	Compounds and methods which modulate feeding behavior and related diseases
OA12514A (en)	1999-12-24	2006-05-29	Aventis Pharma Ltd	Azaindoles.
GB0115109D0 (en) *	2001-06-21	2001-08-15	Aventis Pharma Ltd	Chemical compounds
JP4608215B2 (ja) *	2002-02-01	2011-01-12	アストラゼネカアクチボラグ	キナゾリン化合物
GB0207637D0 (en) *	2002-04-02	2002-05-15	Karobio Ab	Novel compound
SE0301372D0 (sv) *	2003-05-09	2003-05-09	Astrazeneca Ab	Novel compounds
CA2550361C (en) *	2003-12-19	2014-04-29	Prabha Ibrahim	Compounds and methods for development of ret modulators
US20070066641A1 (en) *	2003-12-19	2007-03-22	Prabha Ibrahim	Compounds and methods for development of RET modulators
TWI372624B (en)	2004-03-30	2012-09-21	Vertex Pharma	Azaindoles useful as inhibitors of jak and other protein kinases
US7498342B2 (en) *	2004-06-17	2009-03-03	Plexxikon, Inc.	Compounds modulating c-kit activity
CA2570817A1 (en) *	2004-06-17	2006-01-26	Plexxikon, Inc.	Azaindoles modulating c-kit activity and uses therefor
US7626021B2 (en) *	2004-07-27	2009-12-01	Sgx Pharmaceuticals, Inc.	Fused ring heterocycle kinase modulators
US7361764B2 (en)	2004-07-27	2008-04-22	Sgx Pharmaceuticals, Inc.	Pyrrolo-pyridine kinase modulators
MX2007001126A (es)	2004-07-27	2007-09-25	Sgx Pharmaceuticals Inc	Moduladores de heterociclo cinasa de anillo fusionado.
EP1781654A1 (de)	2004-07-27	2007-05-09	SGX Pharmaceuticals, Inc.	Modulatoren der pyrrolopyridinkinase
ATE527258T1 (de) *	2004-07-28	2011-10-15	Takeda Pharmaceutical	Pyrroloä2,3-cüpyridinverbindung, verfahren zu deren herstellung und anwendung
US20060183758A1 (en) *	2005-02-17	2006-08-17	Cb Research And Development, Inc.	Method for synthesis of AZA-annelated pyrroles, thiophenes, and furans
AU2006272951A1 (en) *	2005-05-17	2007-02-01	Plexxikon, Inc.	Pyrrol (2,3-b) pyridine derivatives protein kinase inhibitors
CN102206216B (zh) *	2005-06-22	2014-11-12	普莱希科公司	作为蛋白质激酶抑制剂的吡咯并[2,3-b]吡啶衍生物
CN102532133A (zh)	2006-01-17	2012-07-04	沃泰克斯药物股份有限公司	适用作詹纳斯激酶抑制剂的吖吲哚类
WO2008063888A2 (en)	2006-11-22	2008-05-29	Plexxikon, Inc.	Compounds modulating c-fms and/or c-kit activity and uses therefor
PE20081581A1 (es) *	2006-12-21	2008-11-12	Plexxikon Inc	COMPUESTOS PIRROLO[2,3-b]PIRIDINAS COMO MODULADORES DE QUINASA
WO2008079909A1 (en) *	2006-12-21	2008-07-03	Plexxikon, Inc.	Pyrrolo [2,3-b] pyridines as kinase modulators
AU2007338754A1 (en)	2006-12-21	2008-07-03	Vertex Pharmaceuticals Incorporated	5-cyan0-4- (pyrrolo [2, 3B] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
AU2007336811A1 (en)	2006-12-21	2008-07-03	Plexxikon, Inc.	Compounds and methods for kinase modulation, and indications therefor
JP2010533729A (ja)	2007-07-17	2010-10-28	プレキシコン，インコーポレーテッド	キナーゼ調節のための化合物と方法、及びそのための適応
FR2946345B1 (fr)	2009-06-05	2011-05-20	Galderma Res & Dev	Nouveaux derives dioxo-imidazolidine, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant.
FR2946342B1 (fr)	2009-06-05	2011-06-24	Galderma Res & Dev	Nouveaux derives de dioxo-imidazolidine, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant.
FR2946346B1 (fr)	2009-06-05	2011-05-20	Galderma Res & Dev	Nouveaux derives dioxo-imidazolidine, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant.
FR2946340B1 (fr)	2009-06-05	2011-06-24	Galderma Res & Dev	Nouveaux n-phenyl acetamie, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant.
KR101739994B1 (ko)	2009-04-03	2017-05-25	에프. 호프만-라 로슈 아게	프로판-１-술폰산 ｛３-［５-（４-클로로-페닐）-１Ｈ-피롤로［２，３-ｂ］피리딘-３-카르보닐］-２，４-디플루오로-페닐｝-아미드 조성물 및 그의 용도
RS57869B1 (sr)	2009-06-17	2018-12-31	Vertex Pharma	Inhibitori replikacije virusa gripa
US8329724B2 (en)	2009-08-03	2012-12-11	Hoffmann-La Roche Inc.	Process for the manufacture of pharmaceutically active compounds
NZ599866A (en)	2009-11-06	2014-09-26	Plexxikon Inc	Compounds and methods for kinase modulation, and indications therefor
WO2012003544A1 (en) *	2010-07-09	2012-01-12	The Walter And Eliza Hall Institute Of Medical Research	Protein kinase inhibitors and methods of treatment
AU2011343642A1 (en)	2010-12-16	2013-05-02	Vertex Pharmaceuticals Incorporated	Inhibitors of influenza viruses replication
KR101911972B1 (ko)	2011-02-07	2018-10-25	플렉시콘 인코퍼레이티드	키나제 조절을 위한 화합물 및 방법, 및 그에 대한 적응증
TWI558702B (zh)	2011-02-21	2016-11-21	普雷辛肯公司	醫藥活性物質的固態形式
UA118010C2 (uk)	2011-08-01	2018-11-12	Вертекс Фармасьютікалз Інкорпорейтед	Інгібітори реплікації вірусів грипу
US9150570B2 (en)	2012-05-31	2015-10-06	Plexxikon Inc.	Synthesis of heterocyclic compounds
RS59144B1 (sr)	2013-11-13	2019-09-30	Vertex Pharma	Inhibitori replikacije virusa influence
HRP20181272T1 (hr)	2013-11-13	2018-10-05	Vertex Pharmaceuticals Incorporated	Postupci priprave inhibitora replikacije virusa influence
JP6704416B2 (ja)	2015-05-13	2020-06-03	バーテックスファーマシューティカルズインコーポレイテッドＶｅｒｔｅｘＰｈａｒｍａｃｅｕｔｉｃａｌｓＩｎｃｏｒｐｏｒａｔｅｄ	インフルエンザウイルスの複製の阻害剤を調製する方法
JP6857617B2 (ja)	2015-05-13	2021-04-14	バーテックスファーマシューティカルズインコーポレイテッドＶｅｒｔｅｘＰｈａｒｍａｃｅｕｔｉｃａｌｓＩｎｃｏｒｐｏｒａｔｅｄ	インフルエンザウイルスの複製の阻害剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR1261179A (fr) *	1959-02-04	1961-05-19	Chimiotherapie Lab Franc	12-aza déserpidine et son procédé de préparation
US3354174A (en) *	1964-02-19	1967-11-21	Sterling Drug Inc	1-and 2-benzimidazolyl-lower-alkylamidoximes, amidines-, and guanidines
NZ221717A (en) *	1986-09-10	1990-08-28	Sandoz Ltd	Azaindole and indolizine derivatives and pharmaceutical compositions
DE3882732T2 (de) *	1987-02-10	1993-12-02	Abbott Lab	Indol, Benzofuran, Benzothiophen enthaltende, Lipoxygenase hemmende Verbindungen.
US5153226A (en) *	1989-08-31	1992-10-06	Warner-Lambert Company	Acat inhibitors for treating hypocholesterolemia
WO1991004027A1 (en) *	1989-09-15	1991-04-04	Pfizer Inc.	New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat)
DE4022414A1 (de) *	1990-07-13	1992-01-16	Bayer Ag	Substituierte pyrrolo-pyridine
FR2674522B1 (fr) *	1991-03-26	1993-07-16	Lipha	Nouveaux derives de l'indole, procedes de preparation et medicaments les contenant.

1992
- 1992-02-14 FR FR9201701A patent/FR2687402B1/fr not_active Expired - Fee Related
1993
- 1993-02-01 IL IL104573A patent/IL104573A0/xx unknown
- 1993-02-04 US US08/013,427 patent/US5338849A/en not_active Expired - Fee Related
- 1993-02-08 ZA ZA93844A patent/ZA93844B/xx unknown
- 1993-02-09 NZ NZ245869A patent/NZ245869A/en unknown
- 1993-02-10 OA OA60340A patent/OA09775A/fr unknown
- 1993-02-10 CZ CZ93168A patent/CZ16893A3/cs unknown
- 1993-02-11 MX MX9300745A patent/MX9300745A/es unknown
- 1993-02-12 CA CA002089470A patent/CA2089470A1/en not_active Abandoned
- 1993-02-12 EP EP93400366A patent/EP0557171B1/de not_active Expired - Lifetime
- 1993-02-12 HR HR930180A patent/HRP930180A2/hr not_active Application Discontinuation
- 1993-02-12 HU HU9300372A patent/HUT64067A/hu unknown
- 1993-02-12 ES ES93400366T patent/ES2076827T3/es not_active Expired - Lifetime
- 1993-02-12 AT AT93400366T patent/ATE125257T1/de not_active IP Right Cessation
- 1993-02-12 MA MA23089A patent/MA22797A1/fr unknown
- 1993-02-12 TN TNTNSN93016A patent/TNSN93016A1/fr unknown
- 1993-02-12 LV LVP-93-119A patent/LV10453B/en unknown
- 1993-02-12 AU AU33005/93A patent/AU658475B2/en not_active Ceased
- 1993-02-12 SI SI19939300076A patent/SI9300076A/sl unknown
- 1993-02-12 DK DK93400366.6T patent/DK0557171T3/da active
- 1993-02-12 NO NO93930505A patent/NO930505L/no unknown
- 1993-02-12 LT LTIP339A patent/LT3065B/lt not_active IP Right Cessation
- 1993-02-12 SK SK9093A patent/SK9093A3/sk unknown
- 1993-02-12 JP JP5023965A patent/JPH061788A/ja active Pending
- 1993-02-12 DE DE69300268T patent/DE69300268T2/de not_active Expired - Fee Related
- 1993-02-13 KR KR1019930001980A patent/KR930017905A/ko not_active Withdrawn
1995
- 1995-10-04 GR GR950402727T patent/GR3017614T3/el unknown

Also Published As

Publication number	Publication date
DE69300268D1 (de)	1995-08-24
JPH061788A (ja)	1994-01-11
SK9093A3 (en)	1993-09-08
LT3065B (en)	1994-10-25
ES2076827T3 (es)	1995-11-01
AU658475B2 (en)	1995-04-13
GR3017614T3 (en)	1996-01-31
HUT64067A (en)	1993-11-29
OA09775A (fr)	1993-11-30
EP0557171A1 (de)	1993-08-25
AU3300593A (en)	1993-08-19
MA22797A1 (fr)	1993-10-01
US5338849A (en)	1994-08-16
IL104573A0 (en)	1993-06-10
FR2687402B1 (fr)	1995-06-30
HRP930180A2 (en)	1995-10-31
CZ16893A3 (en)	1993-12-15
LTIP339A (en)	1994-06-15
FR2687402A1 (fr)	1993-08-20
NO930505L (no)	1993-08-16
LV10453A (lv)	1995-02-20
DK0557171T3 (da)	1995-12-04
KR930017905A (ko)	1993-09-20
HU9300372D0 (en)	1993-04-28
LV10453B (en)	1995-10-20
EP0557171B1 (de)	1995-07-19
CA2089470A1 (en)	1993-08-15
SI9300076A (en)	1993-09-30
TNSN93016A1 (fr)	1994-03-17
MX9300745A (es)	1993-09-01
ZA93844B (en)	1994-08-08
NO930505D0 (no)	1993-02-12
NZ245869A (en)	1995-05-26
DE69300268T2 (de)	1996-04-04

Legal Events

Date	Code	Title	Description
1996-03-15	UEP	Publication of translation of european patent specification
1997-05-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE125257T1 (de)	1995-08-15	Azaindole, deren herstellungsverfahren und sie enthaltende arzneimittel.
ATE174917T1 (de)	1999-01-15	Pyrazolo(1,5-a>pyrimidinderivate und sie enthaltende antiinflammatorische mittel
FR2678938B1 (fr)	1993-10-08	Derives de pyrrolidine, leur preparation et les medicaments les contenant.
ATE170510T1 (de)	1998-09-15	3-(hydroxybenzylidenyl)-indolin-2-one und diese enthaltende arzneimittel
PT734383E (pt)	2002-12-31	Derivados de amidas ciclicas como antagonistas da neuroquinina a
KR860004894A (ko)	1986-07-14	벤조옥사졸- 및 벤조티아졸아민 유도체의 제조방법
FI946073A0 (fi)	1994-12-23	Vitamiini D-sarjan, 20-asemassa modifioituja johdannaisia, menetelmä tällaisten johdannaisten valmistamiseksi, menetelmässä käytettäviä välituotteita, mainittuja johdannaisia sisältäviä farmaseuttisia valmisteita ja johdannaisten käyttö lääkeaineiden valmistamiseen
ATE113282T1 (de)	1994-11-15	Heteroaryl piperazine als antipsychotische mittel.
NO933200L (no)	1994-03-10	Substituerte cykloheksanderivater, fremgangsmåte til fremstilling derav og anvendelsen av forbindelsene til behandling av sykdommer
ATE101612T1 (de)	1994-03-15	Serotonin-antagonisten, ihre herstellung und sie enthaltende arzneimittel.
DE69009195D1 (de)	1994-07-07	Isoxazol-Derivate mit Anti-Serotonin-Aktivität, deren Herstellungsverfahren und diese enthaltende Zusammensetzungen.
ATE137223T1 (de)	1996-05-15	Leukotrien-b4-antagonisten
DE58909620D1 (de)	1996-04-18	Cephalosporinderivate
AU4872793A (en)	1994-04-14	New ellipticine compounds, a process for their preparation and pharmaceutical compositions containing them
FI103046B1 (fi)	1999-04-15	Menetelmä lääkeaineina käyttökelpoisten pyrrolidinyylitiokarbapeneemijohdannaisten valmistamiseksi
ZA932359B (en)	1994-06-15	3-Aminochroman spiro compounds processes for preparing them and pharmaceutical compositions containing them
DE69416540D1 (de)	1999-03-25	Heterocyclische Verbindungen und pharmazeutische Verwendung
ATE188212T1 (de)	2000-01-15	2-pyrazinylethylamin-derivate und ihre verwendung als arzneimittel.
PL352172A1 (en)	2003-07-28	Derivatives of n-alkoxyalkylo-n,n-dialkyloamine or salts thereof and the agents containing these compounds used in treatment of neurodegenerative diseases
DE3772172D1 (de)	1991-09-19	Pyrrol-derivate, ihre herstellung und pharmazeutische zusammenstellungen, die sie enthalten.
AU4930797A (en)	1998-07-02	New ellipticine compounds, a process for their preparation and pharmaceutical compositions containing them